Facebook pixelCenter for BrainHealth Researchers Develop Groundbreaking Biomarker to Predict Cognitive Change in Multiple Sclerosis
Go to home page
Go to home page

Center for BrainHealth Researchers Develop Groundbreaking Biomarker to Predict Cognitive Change in Multiple Sclerosis

Dinesh Sivakolundu, MD, the study’s lead author, is a physician and a doctoral student; Kathryn West, PhD is a post-doctoral fellow and a biomedical engineer; Bart Rypma, PhD is a cognitive neuroscientist and the principal investigator in the NeuroPsychometric Research Lab.

Center for BrainHealth

Patent-pending technology has broader applications to evaluate efficacy of treatments.Researchers at the Center for BrainHealth®, part of The University of Texas at Dallas, recently completed a study that assessed the stiffness of blood vessels in individuals with multiple sclerosis (MS) to provide a predictive measure of their cognitive change. The “arterial compliance index” (ACI) is a novel biomarker reflecting the extent of injury in brain blood vessels, which could help monitor the disease, aid in treatment, and distinguish between people who are prone to develop cognitive impairment and those who are not. Cognitive slowing – reductions in processing speed, the speed with which an individual can think, recall information, and solve problems – occurs in about 70% of MS patients. Processing speed deficits have detrimental effects on day-to-day functioning. Center for BrainHealth researchers wanted to understand how the brains of those MS patients that experience cognitive slowing differ from those MS patients who do not. They investigated 30 MS patients and 14 age-, sex- and education-matched healthy individuals. The MS patients were further divided into cognitively normal and slow groups based on their processing speed. Participants underwent a 10-minute scan using cutting-edge dual-echo functional magnetic resonance imaging (fMRI) that allowed researchers to simultaneously record brain activity and brain blood-flow. Study participants also underwent a comprehensive neuropsychological evaluation, both during and after MRI scanning. “Until now, most research has focused on either global or regional blood vessel stiffness in the brain without taking into account how blood vessels are organized in the brain, how MS affects this organization, and its effects on cognition,” explained Dinesh Sivakolundu, MD, the study’s lead author and a doctoral student in Dr. Bart Rypma’s NeuroPsychometric Research Lab at the Center for BrainHealth. The researchers developed a patent-pending technology, which utilizes novel analysis techniques of MRI scans to assess the elasticity of arteries and veins in nested layers of the brain, and provides biomarkers to reflect the integrity of the arterial and venous systems along the vascular tree in the brain. Through this approach, they found that cognitively slow MS patients had stiffer arteries along the vascular tree in the brain when compared to both cognitively normal MS patients and healthy control participants. By associating the arterial compliance index (ACI) with individual reaction time, researchers were able – for the first time ever – to create a predictor of future cognitive decline. The potential to predict cognitive performance in MS compared to currently available metrics (age, disease duration, Expanded Disability Status Scale, total lesion volume, brain atrophy, 9-hole peg test performance) revealed that ACI performed approximately 15% better than all other currently available MS metrics combined. The results are published in Multiple Sclerosis Journal (August 2019). “By providing a predictor of future cognitive change, this groundbreaking technology creates the opportunity for early intervention,” added Rypma. “This is very significant in MS, and also potentially in other instances that will benefit from the ability to predict cognitive course. The results of this study indicate a need for further research with a broader population.” About Center for BrainHealthCenter for BrainHealth®, part of The University of Texas at Dallas, is a translational research institute committed to enhancing, preserving and restoring brain health across the lifespan. Major research areas include the use of functional and structural neuroimaging techniques to better understand the neurobiology supporting cognition and emotion in health and disease. This leading-edge scientific exploration is translated quickly into practical innovations to improve how people think, work and live, empowering people of all ages to unlock their brain potential. Translational innovations build on Strategic Memory Advanced Reasoning Tactics (SMART™), a proprietary methodology developed and tested by BrainHealth researchers and other teams over three decades.

Share this article

Bart Rypma, PhD

Principal Investigator Professor, Behavioral and Brain Sciences at UT Dallas Meadows Foundation Endowed Chair in Behavioral and Brain Sciences Director, Sammons BrainHealth Imaging Center

RELATED INFORMATION

Cognitive Training for Mild Traumatic Brain Injury and Posttraumatic Stress Disorder

In this study, collaborators at University of Colorado – Colorado Springs completed a study using SMART™, essentially modeling the protocol used in the center's TBI research.